Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cutting antibiotic use has no adverse affect on cattle health and welfare - study 
The growing threat of antimicrobial resistance has put pressure on the livestock industry to reduce its use of antibiotics.
Researchers analyse data from seven dairy farms

Ceasing the use of certain antibiotics does not have an adverse effect on the health, welfare or production of dairy cows, according to new research.

In the study, researchers collected data from seven dairy farms in North Somerset that had stopped using the ‘highest priority critically important antimicrobials’ (HP-CIAs), as recommended by the World Health Organisation.

The findings, published in Vet Record, suggest that the health and welfare of dairy cattle can be maintained - and even improved - without the use of HP-CIAs. They also indicate that the complete cessation of HP-CIAs can lead to an overall reduction of antibiotic use on dairy farms.

“A cessation of the use of HP-CIAs and a decrease in the use of AMs within the livestock industry should be a key target for farmers and veterinary surgeons and has been shown to be achievable while maintaining animal health, welfare and production,” the authors conclude.

The growing threat of antimicrobial resistance to both human and animal health has put pressure on the livestock industry to reduce its use of antibiotics. In April 2017, the World Health Organisation identified quinolines and third- and fourth- generation cephalosporins as HP-CIAs because of the level of risk to human health.

The study, Ceasing the use of the highest priority critically important antimicrobials does not adversely affect production, health or welfare parameters in dairy cows, was conducted by veterinary researchers at the University of Bristol and the University of Surrey.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.